+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antidiarrhoeals Market by Distribution Channel, Product Type, Form, Mechanism Of Action, Route Of Administration, End User, Application - Global Forecast to 2030- Product Image
Antidiarrhoeals Market by Distribution Channel, Product Type, Form, Mechanism Of Action, Route Of Administration, End User, Application - Global Forecast to 2030- Product Image
Sale

Antidiarrhoeals Market by Distribution Channel, Product Type, Form, Mechanism Of Action, Route Of Administration, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015083
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antidiarrhoeals Market grew from USD 4.03 billion in 2024 to USD 4.25 billion in 2025. It is expected to continue growing at a CAGR of 5.27%, reaching USD 5.49 billion by 2030.

Laying the Groundwork for Antidiarrhoeal Market Opportunities

The prevalence of diarrhoeal disorders continues to impose significant clinical and economic burdens worldwide, driving a critical need for advanced antidiarrhoeal solutions. With evolving patient demographics, shifting healthcare infrastructures, and intensifying research into novel therapeutic mechanisms, stakeholders across the public and private sectors must navigate a complex environment of regulatory oversight, supply chain challenges, and competitive innovation.

This executive summary distills the key forces shaping the global antidiarrhoeal market, providing decision-makers with an authoritative snapshot of current dynamics and strategic imperatives. It articulates emerging trends in distribution, product formulation, and therapeutic modalities, while examining geopolitical factors-such as recent tariff changes-that are redefining cost structures and access pathways. By synthesizing segmentation, regional performance, and competitive positioning, this introduction sets the stage for actionable insight, equipping industry leaders with the knowledge required to make informed investments, prioritize R&D pipelines, and optimize market entry strategies.

Emerging Forces Redefining the Antidiarrhoeal Landscape

A wave of transformative shifts is redefining the antidiarrhoeal arena, propelled by patient-driven demand for personalized interventions and a deeper scientific understanding of gut microbiota. Advances in probiotic formulations and digestive enzyme therapies are complementing traditional adsorbents and anti-motility agents, offering multifaceted approaches to both acute and chronic presentations. Concurrently, the expansion of digital health platforms and telepharmacy channels is empowering patients to access over-the-counter remedies and prescription-based treatments with unprecedented convenience.

In parallel, regulatory frameworks are evolving to accommodate novel modalities. Health authorities are issuing updated guidelines on microbial therapeutics, and industry participants are investing in clinical trials to validate efficacy and safety profiles. This confluence of scientific innovation, digital transformation, and regulatory adaptation underscores a pivotal moment in which the antidiarrhoeal landscape is transitioning from commodity-based solutions to differentiated, evidence-driven offerings.

Unpacking the 2025 U.S. Tariff Wave on Antidiarrhoeal Products

The United States’ imposition of revised tariffs on pharmaceutical imports in 2025 has recalibrated the cost equation for antidiarrhoeal manufacturers and distributors. Raw material components, including key excipients and active compounds sourced from Asia, have seen duty hikes that directly impact production margins. This has compelled firms to reevaluate supply chain configurations, exploring alternatives such as domestic API synthesis and strategic partnerships with regional suppliers to mitigate exposure to import duties.

Higher unit costs have translated into price adjustments across both over-the-counter products and prescription lines, exerting pressure on reimbursement negotiations with payers and pharmacy benefit managers. Some market leaders have opted to absorb a portion of the increased expenses to preserve market share, while others have introduced premium formulations-such as probiotic complexes and extended-release capsules-to justify price differentials. This tariff environment underscores the necessity for agile procurement strategies and proactive engagement with policymakers to advocate for tariff exclusions or rebates on essential therapeutic ingredients.

Deep Dive into Market Segmentation Revealing Growth Hotspots

A granular look at market segmentation uncovers distinct growth drivers across distribution channels, product types, and patient cohorts. Distribution pathways span drug stores, hospital pharmacies, online pharmacies, and retail pharmacies, each exhibiting unique dynamics-drug stores maintain strong otc penetration, while digital storefronts are capitalizing on home delivery and subscription models. Within product classifications, otc formulations continue to capture volume-driven demand, yet prescription therapies are gaining traction for chronic and refractory cases.

Form factors further diversify the landscape: capsules and tablets dominate adult markets, whereas liquid suspensions and powders are preferred in pediatric and geriatric care due to ease of administration. Underpinning these offerings are varying mechanisms of action-adsorbents remain a mainstay for acute symptom control, anti-motility agents address severe spasms, digestive enzymes support malabsorption syndromes, and probiotics target microbiome restoration. The oral route of administration accounts for the lion’s share of utilization, though parenteral options are reserved for hospitalized patients failing to respond to enteral regimens. End-user categories encompass adults, geriatrics, and pediatrics, each influenced by differing safety profiles, dosing preferences, and compliance challenges. Finally, applications span traveller’s diarrhea, chronic diarrhea, and acute episodes, the latter subdivided into infectious and non-infectious classes, with infectious triggers further differentiated among bacterial, parasitic, and viral etiologies. This segmentation framework illuminates high-growth niches and informs targeted innovation strategies.

Regional Dynamics Shaping Antidiarrhoeal Market Growth

Regional landscapes exhibit divergent trajectories in the antidiarrhoeal sector. In the Americas, a robust otc ecosystem and strong consumer health literacy underpin sustained revenue contributions, while reimbursement policies and generic competition influence prescription volume. Meanwhile, Europe, Middle East & Africa navigate a mosaic of regulatory regimes, with the European Union prioritizing harmonized approvals for probiotic and microbiome-based therapies, and select Middle Eastern markets emerging as hubs for clinical research collaborations.

Across Asia-Pacific, rapid urbanization and increased travel corridors are driving heightened demand for both traveller’s diarrhea treatments and preventative measures. Government initiatives to bolster healthcare infrastructure in key markets are expanding hospital pharmacy networks and enabling broader access to advanced antidiarrhoeal compounds. These regional distinctions highlight the need for localized go-to-market approaches that align with regulatory frameworks, payment mechanisms, and consumer behaviors.

Competitive Canvas of Leading Antidiarrhoeal Manufacturers

The competitive arena is populated by incumbent pharmaceutical giants and agile specialty firms vying for market leadership. Legacy players leverage extensive distribution networks and branded product portfolios, while newer entrants differentiate through novel probiotic strains, combination therapies, and patient support programs. Corporate alliances, licensing agreements, and targeted acquisitions are intensifying as companies seek to bolster their pipelines and gain footholds in high-growth segments such as paediatric formulations and traveler’s health solutions.

Innovation is manifest in strategic investments in biotechnology platforms, with companies sponsoring microbiome research and enzyme-engineering initiatives. At the same time, digital engagement strategies-ranging from telehealth partnerships to mobile adherence apps-are becoming critical levers to enhance patient outcomes and foster brand loyalty. This complex competitive tapestry underscores the imperative for continuous product differentiation and strategic agility.

Actionable Strategies to Capitalize on Market Trends

Industry leaders must adopt a multi-pronged approach to secure sustainable growth. First, supply chain diversification is essential to buffer against tariff volatility and raw material shortages, incorporating local manufacturing and regional sourcing agreements. Second, investment in microbiome-oriented R&D will position portfolios at the forefront of personalized gut health solutions, while strategic alliances with academic institutions can accelerate clinical validation.

Enhancing digital channels-particularly online pharmacy integration and telemedicine collaborations-will extend market reach and improve patient adherence. Tailoring dosage forms to specific end-user needs, such as age-appropriate liquids and sustained-release capsules, can maximize therapeutic outcomes. Finally, proactive engagement with regulatory bodies and health insurers to establish value-based pricing models will ensure access and reimbursement for innovative antidiarrhoeal treatments.

Robust Research Framework Ensuring Data Integrity

The findings presented here are underpinned by a rigorous research framework combining both qualitative and quantitative methodologies. Primary research included in-depth interviews with key opinion leaders, senior executives, and clinical specialists across major geographic regions. Secondary research drew upon peer-reviewed journals, regulatory filings, corporate disclosures, and proprietary databases, with data triangulation employed to ensure validity and reliability.

Analytical models were calibrated to account for recent tariff changes and shifting regulatory landscapes, while in-country analysts provided localized insights to capture regional nuances. Throughout the process, strict quality control protocols-such as cross-verification of source data and peer review-were applied to uphold the integrity of conclusions and recommendations.

Consolidating Insights to Steer Strategic Decisions

In consolidating these insights, it becomes clear that the antidiarrhoeal market is undergoing a strategic inflection point. Segmentation analysis highlights targeted opportunities in high-growth channels, formulations, and therapeutic mechanisms. The impact of U.S. tariffs underscores the necessity for agile supply chain management and cost-optimization strategies. Regional dynamics demand localized approaches, and competitive intensity drives continuous innovation and strategic alliances.

By synthesizing these dimensions, industry leaders can chart a course toward sustainable differentiation, leveraging data-driven decision-making to navigate regulatory complexities, evolving patient needs, and disruptive technologies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Distribution Channel
    • Drug Stores
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Product Type
    • Otc
    • Prescription
  • Form
    • Capsule
    • Liquid
    • Powder
    • Tablet
  • Mechanism Of Action
    • Adsorbents
    • Anti-Motility
    • Digestive Enzymes
    • Probiotics
  • Route Of Administration
    • Oral
    • Parenteral
  • End User
    • Adults
    • Geriatrics
    • Pediatrics
  • Application
    • Acute Diarrhea
      • Infectious
        • Bacterial
        • Parasitic
        • Viral
      • Non-Infectious
    • Chronic Diarrhea
    • Traveller’s Diarrhea
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Haleon plc
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Biocodex
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Abbott Laboratories
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antidiarrhoeals Market, by Distribution Channel
8.1. Introduction
8.2. Drug Stores
8.3. Hospital Pharmacies
8.4. Online Pharmacies
8.5. Retail Pharmacies
9. Antidiarrhoeals Market, by Product Type
9.1. Introduction
9.2. Otc
9.3. Prescription
10. Antidiarrhoeals Market, by Form
10.1. Introduction
10.2. Capsule
10.3. Liquid
10.4. Powder
10.5. Tablet
11. Antidiarrhoeals Market, by Mechanism Of Action
11.1. Introduction
11.2. Adsorbents
11.3. Anti-Motility
11.4. Digestive Enzymes
11.5. Probiotics
12. Antidiarrhoeals Market, by Route Of Administration
12.1. Introduction
12.2. Oral
12.3. Parenteral
13. Antidiarrhoeals Market, by End User
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Antidiarrhoeals Market, by Application
14.1. Introduction
14.2. Acute Diarrhea
14.2.1. Infectious
14.2.1.1. Bacterial
14.2.1.2. Parasitic
14.2.1.3. Viral
14.2.2. Non-Infectious
14.3. Chronic Diarrhea
14.4. Traveller’s Diarrhea
15. Americas Antidiarrhoeals Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Antidiarrhoeals Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Antidiarrhoeals Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Johnson & Johnson
18.3.2. Haleon plc
18.3.3. Pfizer Inc.
18.3.4. Reckitt Benckiser Group plc
18.3.5. Biocodex
18.3.6. Cipla Limited
18.3.7. Dr. Reddy's Laboratories Limited
18.3.8. Abbott Laboratories
18.3.9. Sanofi S.A.
18.3.10. Takeda Pharmaceutical Company Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ANTIDIARRHOEALS MARKET MULTI-CURRENCY
FIGURE 2. ANTIDIARRHOEALS MARKET MULTI-LANGUAGE
FIGURE 3. ANTIDIARRHOEALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTIDIARRHOEALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ANTIDIARRHOEALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ANTIDIARRHOEALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTIDIARRHOEALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIDIARRHOEALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ADSORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ANTI-MOTILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DIGESTIVE ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY NON-INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY CHRONIC DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TRAVELLER’S DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CANADA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. CANADA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 66. CANADA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 70. CANADA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 117. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 144. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. ITALY ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. ITALY ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. ITALY ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 148. ITALY ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. ITALY ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ITALY ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ITALY ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 152. ITALY ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 153. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 157. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 161. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 189. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 193. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 197. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 207. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. QATAR ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. QATAR ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 210. QATAR ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 211. QATAR ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. QATAR ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. QATAR ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. QATAR ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 215. QATAR ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 216. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 219. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 243. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 246. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 247. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 251. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 252. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 255. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 256. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 260. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 270. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 273. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 274. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 279. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. POLAND ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. POLAND ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 282. POLAND ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 283. POLAND ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. POLAND ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. POLAND ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. POLAND ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 287. POLAND ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 307. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. CHINA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. CHINA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 310. CHINA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 311. CHINA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. CHINA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. CHINA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. CHINA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 315. CHINA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 316. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. INDIA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDIA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 319. INDIA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 320. INDIA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. INDIA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. INDIA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. INDIA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 324. INDIA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 325. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 328. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 329. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 330. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 333. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHEA, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY END USER, 201

Companies Mentioned

The companies profiled in this Antidiarrhoeals market report include:
  • Johnson & Johnson
  • Haleon plc
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Biocodex
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Abbott Laboratories
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.49 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antidiarrheals Market Report 2025 - Product Image

Antidiarrheals Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Chemotherapy-Induced Diarrhea - Pipeline Insight, 2025 - Product Image

Chemotherapy-Induced Diarrhea - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Traveler's Diarrhea - Pipeline Insight, 2025 - Product Image

Traveler's Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Anti Diarrheal Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Anti Diarrheal Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Antidiarrheals Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antidiarrheals Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 79 Pages
  • Global
From

About the Anti Diarrheal Market

The Anti Diarrheal market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Anti Diarrheal drugs are used to treat diarrhea, which is a common symptom of many gastrointestinal disorders. These drugs work by reducing the amount of water and electrolytes lost in the stool, and by slowing down the movement of the intestines. Commonly used Anti Diarrheal drugs include loperamide, diphenoxylate, and bismuth subsalicylate. The Anti Diarrheal market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Johnson & Johnson, and Novartis. Other companies in the market include Sanofi, Bayer, AstraZeneca, and Daiichi Sankyo. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.